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Effects of inspiratory pressure support on oxygenation 
and central haemodynamics in the normal heart during 
the postoperative period 
0. NBRREGAARD*, T. M. JENSEN AND P. VINDELEV 
Danish Respiratory Center West, University Hospital of Arhus, ,&hus, Denmark 
Ten patients without cardiac disease or pulmonary dysfunction were exposed to an inspiratory pressure of 0, 
10 and 20 cmH,O, in random order, via a nasal mask during the first postoperative day after scoliotic surgery. 
These patients were in the supine position, and a BiPAP respiratory assist device was used. Arterial oxygen 
saturation increased significantly during the application of 10 and 20 cmH,O, while none of the haemo- 
dynamic parameters (cardiac output, central venous pressure, right ventricular ejection fraction, right 
ventricular end diastolic volume, mean pulmonary artery pressure, pulmonary artery wedge pressure, 
pulmonary vascular resistance) changed significantly, contrary to the findings during continuous positive 
airways pressure treatment. In addition, the BiPAP was generally well tolerated by the patients. 
Introduction 
The use of continuous positive airways pressure 
(CPAP) breathing was introduced by Barach et al. 
at the beginning of this century (l), and has since 
been a recognized treatment for a wide variety of 
conditions including respiratory insufficiency (2,3), 
adult respiratory distress syndrome (4), pulmonary 
oedema (5) sleep apnoea (6) and weaning (7). 
While the inspiratory unloading (8) and increased 
oxygenation (9) are beneficial effects of CPAP, the 
haemodynamic effects include a reduction in cardiac 
output (CO) (10,ll) through decreases in venous 
return generated by the positive intrathoracic pres- 
sure (10,12,13), as CO in the normal heart is largely 
dependent on preload (10,13,14). Through the use 
of positive inspiratory pressure (IPAP) alone, with- 
out any expiratory pressure, it might be expected 
that the adverse haemodynamic effects of CPAP 
could be reduced. With the advent of the BiPAP 
respiratory assist device (Respironics), this possi- 
bility is now present in everyday clinical practice. 
The aim of this study was to evaluate the effects of 
IPAP on oxygenation and central haemodynamics in 
a group of postoperative patients without cardiac 
disease. 
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Methods 
A group of 10 consecutive patients operated for 
scoliosis, with no signs of cardiac disease and with 
normal arterial blood gases, were submitted to treat- 
ment with the BiPAP-apparatus. Studies were 
performed in the intensive care unit during the first 
postoperative day in the supine position. Haemo- 
dynamic measurements were performed with a flow- 
directed thermodilution catheter, which was also able 
to measure right ventricular ejection fraction (REF) 
(Refox, Baxter Healthcare Corporation, Santa Ana, 
CA, U.S.A.). The catheter was inserted via the right 
internal jugular vein. Blood pressure was monitored 
through an arterial line. Cardiac output was 
determined as a mean of three measurements by 
the thermodilution technique using ice-cold water. 
Arterial oxygen saturation (SaO,) was measured by 
pulse oximetry. Inspiratory pressure support was 
applied via a nasal mask using the BiPAP ventilatory 
support system (Respironics, Murrysville, PA, 
U.S.A.) while the patients kept their mouths tightly 
closed. Inspiratory pressure support of 0, 10 and 
20 cmH,O was administered in random order while 
the patients were breathing room air and measure- 
ments were obtained 5-10 min later. The BiPAP was 
set in the spontaneous mode. 
Data are presented as median values and 25-75 
percentiles unless stated otherwise. Data were 
analysed using the Kruskal-Wallis and Dunn tests. 
PcO.05 was considered significant. 
0 1996 W. B. Saunders Company Ltd 
416 0. Nerregaard et al. 
Table I 
0 cmH,O 
Median (25-75 percentiles) 
10 cmH,O 20 cmH,O 
Statistics 
Kruskal-Wallis 
co 8.00 (7.21-8.73) 
EDV 189 (165-219) 
SVR 826 (751-925) 
PVR 77.0 (51.5-179.5) 
REF 41.5 (38.U7.0) 
MPAP 22.5 (16G26.0) 
PAWP 11.5 (9.00-14.0) 
SaO, 95.0 (92.5-96.0) 
764 (6.769.15) 
193 (158-205) 
9 11 (696942) 
85.0 (64.8-136.8) 
42.0 (4OC46.0) 
20.5 (16Tb24.0) 
11.5 (7.0-13.0) 
99.0 (97.5-99.0) 
7.68 (6.58-8.74) 
185 (169-204) 
910 (799-1016) 
98.5 (62&l 16.5) 
43.0 (37.044.0) 
21.0 (18.3-24.5) 
15.0 (6.5-16.3) 
99.0 (97~cb-100) 
P=O.64 
P=O.910 
P=O.673 
P=O.898 
P=O.777 
P=O,828 
P=O.702 
P=O.OOl 
Kruskal-Wallis, one way ANOVA on ranks; CO, cardiac output; EDV, end diastolic volume; SVR, systemic vascular 
resistance; PVR, pulmonary vascular resistance; REF, right ventricular ejection fraction; MPAP, mean pulmonary artery 
pressure; PAWP, pulmonary artery wedge pressure; SaO,, arterial oxygen saturation. 
Results 
The study group comprised females of mean age 
14.5 years (range 13-29 years). Baseline values 
were as follows: PaO,, 12.1 kPa/90.8 mmHg (range 
9.3-13.5 kPa/69+-101.3 mmHg); PaCO,, 5.3 kPa/ 
39.8 mmHg (range 4.9-57 kPa/36.842+ mmHg); 
FEV1, 2.35 1 (range 1.63.3 1); FVC, 2.7 1 (range 
1.84.2 1) (nine patients). None of the patients had 
any symptoms of cardiac disease; ECGs presented no 
signs of cardiac disease and X-rays of the thorax 
showed no evidence of cardiac incompensation. 
During the application of 10 and 20 cmH,O IPAP, 
SaO, rose from 95.0% (92+96.0%) to 99.0% (97.5- 
99.0%) (PcO.05) and 99% (97.0-100.0%) (P<O.O5), 
respectively. 
No significant changes were observed in CO, end 
diastolic volume (EDV), systemic vascular resistance 
(SVR), pulmonary vascular resistance (PVR), REF, 
mean pulmonary artery pressure (MPAP), or pul- 
monary artery wedge pressure (PAWP) (Table 1). All 
patients tolerated the nasal mask although some 
discomfort was experienced by some of the patients 
during the application of 20 cm H,O IPAP. 
Discussion 
The two most important findings of this study 
were: (1) arterial oxygenation was improved sig- 
nificantly by the use of the IPAP; and (2) no adverse 
haemodynamic effects could be observed even dur- 
ing the application of an inspiratory pressure of 
20 cmH,O. In addition, the BiPAP (Respironics), a 
portable blower, proved to be effective and generally 
well tolerated in this group of postoperative scoliotic 
patients. As these patients are not easily mobilized in 
the early postoperative period, and often present a 
restrictive pulmonary function pattern carrying a risk 
of atelectasis, the prevention of this through alveolar 
distension is important as a way of reducing post- 
operative complications and days in the hospital. 
The improved SaO, during the use of IPAP 
without supplemental oxygen is compatible with a 
redistribution of lung water (15), and increased lung 
volume obtained by an enlargement of patent alveoli 
and recruitment of new alveoli (16) resulting in better 
ventilation-perfusion matching. This emphasizes 
the importance of a distending pressure during 
inspiration and is in accordance with the results of 
Kumar et al. (9). 
Despite the fact that CPAP alone has been shown 
to increase SaO,, an element of increased ventilation 
during the use of IPAP as a cause of the improved 
SaO, cannot be excluded. 
The authors were not able to produce a sig- 
nificantly better SaO, by raising IPAP from 10 to 
20cmH,O, suggesting that the effect of IPAP was 
predominantly an enlargement of patent alveoli 
rather than alveolar recruitment. 
As the increase in IPAP (from 10 to 20 cmH,O) 
was not accompanied by any change in central 
venous pressure (CVP), REF, PAWP, right ventricu- 
lar EDV or CO, it seems that the application of IPAP 
without intended EPAP does not increase right 
ventricular afterload to any measurable extent as 
CPAPIPEEP is known to do (17). 
Although the pressure in the mask is not zero 
throughout the entire expiratory phase, the system 
does continue to leak through the slots of the whisper 
swivel attached to the mask, even with the patient’s 
mouth closed. The pressure in the mask thus 
approaches zero during the expiratory phase. 
Inspiratory pressure support 417 
In other aspects, the haemodynamic effects found 
in this study are contrary to the results obtained from 
the use of CPAP in animals (10,ll) as well as in 
human studies (13, 18), where an increased CPAP 
resulted in a reduced CO when applied to the normal 
heart. The normal heart is largely dependent on 
preload (10, 13), and the positive airway pressure 
produced by the CPAP increases the intrathoracic 
pressure thus compromising the venous return. In the 
failing heart, being primarily dependent on afterload, 
the effect of an increased intrathoracic pressure seems 
to augment CO via a reduction of the afterload. This 
is in agreement with the observation that vasodilators 
can augment CO in hearts with impaired contractility 
(19,20). 
The absence of adverse haemodynamic effects 
during the use of inspiratory pressure support with- 
out expiratory resistance suggests the importance of 
periods of low intrathoracic pressure during the 
respiratory cycle, allowing normal venous return to 
be established. The present findings of undisturbed 
CVP, PVR, right ventricular EDV and REF during 
the different levels of IPAP applied suggest an un- 
disturbed venous return. To the extent that aug- 
mented CO in the failing heart is a result of an 
increased intrathoracic pressure, one would not 
expect IPAP, but rather CPAP or a combination of 
the two, to be the optimal treatment in patients with 
chronic heart failure. 
In conclusion, this study demonstrated a beneficial 
effect of IPAP on oxygenation equal to that of 
CPAP, but unlike during CPAP treatment, no 
adverse haemodynamic effects could be demon- 
strated in the normal heart. In addition, the BiPAP 
was generally well tolerated and thus practicable 
in this group of patients, where prevention of 
atelectases is of major importance. 
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